Enovis ENOV Foreign locations — Net Sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Enovis in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Enovis’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Enovis's foreign locations — net sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Enovis's foreign locations — net sales?
- Enovis (ENOV) reported foreign locations — net sales of $238.18M in Q4 2025.
- How has Enovis's foreign locations — net sales changed year-over-year?
- Enovis's foreign locations — net sales increased by 10.5% year-over-year, from $215.49M to $238.18M.
- What is the long-term trend for Enovis's foreign locations — net sales?
- Over 4 years (2021 to 2025), Enovis's foreign locations — net sales has grown at a 24.6% compound annual growth rate (CAGR), from $395.75M to $952.72M.
- What does foreign locations — net sales mean?
- This metric represents the total revenue generated from sales to customers located outside of the company's primary country of domicile. It reflects the organization's geographic footprint and its ability to capture market share in international medical technology markets. Monitoring this figure helps investors assess the company's global expansion strategy and exposure to foreign currency fluctuations and international regulatory environments.